Commission Implementing Regulation (EU) 2022/634 of 13 April 2022 amending Regulation (EU) No 37/2010 as regards the classification of the substance bambermycin with respect to its maximum residue limit in foodstuffs of animal origin (Text with EEA relevance)

• CELEX: Implementing Regulation (EU) 2022/634
• Articles: 3

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘bambermycin’ is replaced by the following:

Pharmacologically active Substance

Marker residue

Animal Species

MRL

Target Tissues

Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic Classification

‘Bambermycin

NOT APPLICABLE

Rabbit

No MRL required

NOT APPLICABLE

For oral use only

Anti-infectious agent/Antibiotics’

Flavophos-pholipol A

Poultry

100 μg/kg

Muscle

Not for use in animals from which eggs are produced for human consumption

100 μg/kg

Skin and fat in natural proportions

3 000 μg/kg

Liver

20 000 μg/kg

Kidney